These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 33177116)

  • 1. Inflammatory Bowel Disease Is More Common in Patients with IgA Nephropathy and Predicts Progression of ESKD: A Swedish Population-Based Cohort Study.
    Rehnberg J; Symreng A; Ludvigsson JF; Emilsson L
    J Am Soc Nephrol; 2021 Feb; 32(2):411-423. PubMed ID: 33177116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer risk in patients with immunoglobulin A nephropathy: a Swedish population-based cohort study.
    Rehnberg J; Ludvigsson JF; Carrero JJ; Emilsson L
    Nephrol Dial Transplant; 2022 Mar; 37(4):749-759. PubMed ID: 34788864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcomes of end-stage kidney disease for patients with IgA nephropathy: A multi-centre registry study.
    Zhang L; Liu X; Pascoe EM; Badve SV; Boudville NC; Clayton PA; De Zoysa J; Hawley CM; Kanellis J; McDonald SP; Peh CA; Polkinghorne KR; Johnson DW
    Nephrology (Carlton); 2016 May; 21(5):387-96. PubMed ID: 26393772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantifying Duration of Proteinuria Remission and Association with Clinical Outcome in IgA Nephropathy.
    Canney M; Barbour SJ; Zheng Y; Coppo R; Zhang H; Liu ZH; Matsuzaki K; Suzuki Y; Katafuchi R; Reich HN; Cattran D; ;
    J Am Soc Nephrol; 2021 Feb; 32(2):436-447. PubMed ID: 33514642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Association of Low Hemoglobin Levels with IgA Nephropathy Progression: A Two-Center Cohort Study of 1,828 Cases.
    Zhu B; Liu WH; Yu DR; Lin Y; Li Q; Tong ML; Li YY; Yang RC; Du YY; Tang XL; Jiang F; Fei D; Wei XY; Zhang FF; Yin JZ; Wang WR; Li XF; Sun Y; Zhong YZ; Zhang MJ; Cheng XX; Zhu CF; Chen HY
    Am J Nephrol; 2020; 51(8):624-634. PubMed ID: 32694247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical decision support system for end-stage kidney disease risk estimation in IgA nephropathy patients.
    Pesce F; Diciolla M; Binetti G; Naso D; Ostuni VC; Di Noia T; Vågane AM; Bjørneklett R; Suzuki H; Tomino Y; Di Sciascio E; Schena FP
    Nephrol Dial Transplant; 2016 Jan; 31(1):80-6. PubMed ID: 26047632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma Galactose-Deficient IgA1 and C3 and CKD Progression in IgA Nephropathy.
    Chen P; Yu G; Zhang X; Xie X; Wang J; Shi S; Liu L; Lv J; Zhang H
    Clin J Am Soc Nephrol; 2019 Oct; 14(10):1458-1465. PubMed ID: 31511226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of normal-range serum phosphorus with immunoglobulin A nephropathy progression: a retrospective cohort study.
    An X; Ding L; Yang Y; Yang Z; Zhang Y; Bai F; Liu L; Shi W; Yang X
    Int Urol Nephrol; 2024 Jan; 56(1):275-282. PubMed ID: 37336802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimated plasma osmolarity and risk of end-stage kidney disease in patients with IgA nephropathy.
    Tanaka S; Nakano T; Tokumoto M; Masutani K; Tsuchimoto A; Ooboshi H; Kitazono T
    Clin Exp Nephrol; 2020 Oct; 24(10):910-918. PubMed ID: 32594371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tonsillectomy delays progression of advanced IgA nephropathy to end-stage kidney disease.
    Komatsu H; Fujimoto S; Kikuchi M; Sato Y; Kitamura K
    Ren Fail; 2012; 34(4):448-53. PubMed ID: 22260382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient classification and outcome prediction in IgA nephropathy.
    Diciolla M; Binetti G; Di Noia T; Pesce F; Schena FP; Vågane AM; Bjørneklett R; Suzuki H; Tomino Y; Naso D
    Comput Biol Med; 2015 Nov; 66():278-86. PubMed ID: 26453758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary Plasminogen as a Marker of Disease Progression in Human Glomerular Disease.
    de Cos M; Mosoyan G; Chauhan K; Troost JP; Wong JS; Lefferts S; Morgan P; Meliambro K; Egerman M; Ray J; Parker T; Levine D; Seshan S; Bardash Y; Horowitz B; Kent CA; Shaw MM; Perlman A; Moledina DG; Coca SG; Campbell KN
    Am J Kidney Dis; 2024 Aug; 84(2):205-214.e1. PubMed ID: 38452919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. My journey on the path to understanding IgA nephropathy: From bench to bedside.
    Tomino Y
    Nephrology (Carlton); 2024 Sep; 29 Suppl 2():51-54. PubMed ID: 39327760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes of tonsillectomy for IgA nephropathy patients: A retrospective cohort study, two-centre analysis with the inverse probability therapy weighting method.
    Matsumoto K; Ikeda Y; Yamaguchi S; Sanematsu M; Fukuda M; Takashima T; Kishi T; Miyazono M; Uchiumi S; Yoshizaki M; Nonaka Y; Matsumoto R; Kanaya A; Fukunari K; Ikeda Y
    Nephrology (Carlton); 2018 Sep; 23(9):846-854. PubMed ID: 28703898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive agents for treating IgA nephropathy.
    Natale P; Palmer SC; Ruospo M; Saglimbene VM; Craig JC; Vecchio M; Samuels JA; Molony DA; Schena FP; Strippoli GF
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD003965. PubMed ID: 32162319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preeclampsia and risk of end stage kidney disease: A Swedish nationwide cohort study.
    Khashan AS; Evans M; Kublickas M; McCarthy FP; Kenny LC; Stenvinkel P; Fitzgerald T; Kublickiene K
    PLoS Med; 2019 Jul; 16(7):e1002875. PubMed ID: 31361741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression of IgA nephropathy under current therapy regimen in a Chinese population.
    Li X; Liu Y; Lv J; Shi S; Liu L; Chen Y; Zhang H
    Clin J Am Soc Nephrol; 2014 Mar; 9(3):484-9. PubMed ID: 24408121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgA Nephropathy Susceptibility Loci and Disease Progression.
    Shi M; Ouyang Y; Yang M; Yang M; Zhang X; Huang W; Wang W; Wang Z; Zhang W; Chen X; Pan X; Ren H; Chen N; Xie J
    Clin J Am Soc Nephrol; 2018 Sep; 13(9):1330-1338. PubMed ID: 30042224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality in IgA Nephropathy: A Nationwide Population-Based Cohort Study.
    Jarrick S; Lundberg S; Welander A; Carrero JJ; Höijer J; Bottai M; Ludvigsson JF
    J Am Soc Nephrol; 2019 May; 30(5):866-876. PubMed ID: 30971457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cigarette smoking and progression of IgA nephropathy.
    Yamamoto R; Nagasawa Y; Shoji T; Iwatani H; Hamano T; Kawada N; Inoue K; Uehata T; Kaneko T; Okada N; Moriyama T; Horio M; Yamauchi A; Tsubakihara Y; Imai E; Rakugi H; Isaka Y
    Am J Kidney Dis; 2010 Aug; 56(2):313-24. PubMed ID: 20471735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.